Medical Representative Interview Questions

"I studied pharmacy, and during my internship I spent some weeks at a retail counter. I noticed I enjoyed explaining why one medicine suits a patient better than another far more than I enjoyed dispensing. A medical rep does that same explaining, but with doctors, which is harder and more interesting to me. I also know what the job really involves: long days on the road, doctors who make you wait an hour for two minutes, and a monthly target. I played competitive cricket through college, so I'm used to losing a match and turning up for the next one. In a few years I'd like to manage an area and train new reps, and I think starting in the field is the honest way to earn that."

"I have a science degree with pharmacology and human physiology as core subjects, so terms like mechanism of action or dosing don't scare me. After graduating I spent a year selling diagnostic test packages to clinics. That taught me how to get past the front desk, how to say something useful in the first few seconds, and how to follow up without being a nuisance. One moment brought both together: a clinic doctor asked me why a particular test was worth adding for his diabetic patients, and because I understood the physiology I could explain it simply. He started sending patients to our lab after that. I think that mix of science and field selling is exactly what this role asks for."

"From your website and product list, your strongest areas look like cardiology and diabetes, with a growing range in gastro. That means most of your calls are with physicians, cardiologists and diabetologists, plus a lot of work with the chemists near those clinics. The product I'd most like to start with is your diabetes combination, because I understand how the two molecules work together, and diabetes patients see their doctor regularly, so there's a steady reason to build a relationship. I'd want your training first, of course, especially on the approved claims and the competing brands, but I'd feel confident walking into a physician's room with it."

"A medical representative is the link between the company and the doctors who prescribe its medicines. My main job is to meet doctors in my territory and give them accurate, approved information about our products: what they're for, how they work, how to dose them and what to watch for, so they're used for the right patients. But it isn't only talking. I also make sure the chemists and stockists near those doctors actually have the stock, because a prescription the chemist can't fill is lost. And I bring information back: questions our medical team should answer, what competitors are doing, and any side effect reports, which go to our safety team straight away. Doctors have very little time to keep up with every new product, so a rep who's accurate and brief saves them effort. That's why the role still matters."

"In my first sales job there was a senior physician who wouldn't see me. Four visits in a row, the receptionist said he was busy. Instead of coming back at the same time again, I asked the receptionist when he was least rushed, and she said right after his evening clinic. I also stopped asking for a meeting and left a one-page summary of a new study with a note saying I'd take two minutes to explain it whenever he wanted. On the sixth visit he called me in, asked three sharp questions, and from then on he'd see me once a month. What kept me going was treating each no as information about timing and approach, not as a verdict on me."

"I treat it like a job with a boss watching even when there isn't one. I start at the same time every day, with the call plan written the night before, so I never lose the morning deciding where to go. I set myself small daily goals, like getting one doctor to agree to try a product, which makes a long day feel like progress. After a bad day I don't carry it over; I note what I'd do differently and then switch off. I also stay in touch with the other reps in my area, because swapping what's working with a particular doctor keeps me sharp. Honestly, I like the freedom, and the way I keep it is by making sure my numbers never give anyone a reason to watch me closely."

"Last year I missed my quarter on our main blood pressure brand by a clear margin. My first instinct was to blame a competitor's price cut, but when I looked at the chemist data, most of the drop came from just two high-prescribing physicians who had quietly switched. I'd been seeing them on schedule but mostly talking about our newer product. So I went back to both and asked directly what had changed. One said his patients were complaining about cost at the chemist next door. I worked with the stockist so that chemist carried our smaller, cheaper pack, and I brought the doctor updated information on it. The next quarter I was back above target. The lesson was to check my top prescribers every week, not just my overall total."

"First I'd look at where the gap actually is: which products, which chemists, which doctors. Usually a few key prescribers or one stockist explain most of it. Then I'd change my call plan so my highest-potential doctors get an extra visit, and I'd check stock at the chemists around them, because sometimes the prescriptions are there and the stock isn't. I'd follow up on any trial promises doctors made earlier in the month. I'd tell my manager that same day where I stand and what I'm doing, not on the last day. What I wouldn't do is push stockists to take far more than they can sell, because it comes back as returns and next month starts even further behind."

"On activity, most managers look at call average, meaning doctors seen per day, coverage, meaning how many listed doctors I met in the month, and frequency, meaning whether key doctors got the number of visits they should. Chemist calls and stock checks count too. On results, it's sales against target by product, mostly secondary sales, and how many new doctors started prescribing. If I had to pick one, I'd watch coverage and frequency on my key doctors, because that's fully in my control and drives everything else. A high call average means nothing if I'm seeing easy doctors who don't prescribe in our areas. But in the end the target is sales, so I'd check both every week, not just at month end."

"In my last role I covered three small towns, each about an hour apart, and most days I was out from early morning until after the evening clinics. What made it work was planning the week on Sunday night and grouping calls so I covered one town fully each day instead of zigzagging. I packed my samples and literature by route the night before, and I filled in my call report after each visit rather than at midnight. I also made a rule to stop for a proper lunch, because I noticed my last calls were weak when I skipped it. Over six months I didn't miss a planned visit to any of my key doctors. If I did it again, I'd use the driving time for product training recordings."

"In week one I'd gather everything: the doctor list from my predecessor, past sales by chemist, and the stockist details. I'd walk the main areas and meet the key chemists, because they know which doctors write the most. Then I'd classify doctors by potential for our products: A for high prescribers in our therapy areas, B for medium, C for the rest, and set visit frequency to match, so the A group sees me several times a month and C maybe once. Next I'd split the territory into areas and give each a fixed day of the week, so I'm not criss-crossing town. Each daily plan would mix A and B doctors with the chemists near them. Every week I'd compare coverage with the plan and move doctors between groups as I learn more."

"Two weeks before my final-year viva, my guide changed my project topic to a newer class of diabetes drugs I'd barely studied. I read review articles first to get the big picture, then drew the mechanism by hand until I could explain it without notes. I tested myself by explaining it to a friend studying commerce; if she didn't get it, I knew my explanation wasn't clear yet. In the viva, the external examiner, a senior physician, asked how the drug lowers sugar and what side effects to watch for. I answered in two plain sentences and gave more detail only when he asked. He told my guide it was one of the clearest answers he'd heard that day. That's the same skill I'd use every time a new product launches."

"The generic name is the name of the active molecule, like amlodipine or metformin, and it's the same whoever makes it. The brand name is the trade name one company gives its own version. So there can be many brands of one molecule, and the doctor chooses between them. That matters every day, because often my brand and a competitor's contain exactly the same molecule at the same strength, and I can't claim ours works differently if it doesn't. What I can talk about is what's true and approved: manufacturing quality, pack sizes, cost to the patient, availability at nearby chemists, and the information and support the company gives. And I need to know the molecule itself well enough to answer any question about it."

"The main groups start with ACE inhibitors, like ramipril, which can cause a dry cough in some patients. ARBs, like telmisartan or losartan, act on the same hormone system but rarely cause that cough, so they're often used when a patient can't take an ACE inhibitor. Calcium channel blockers, like amlodipine, relax the blood vessels, and ankle swelling is the side effect doctors mention most. Thiazide-type diuretics, like hydrochlorothiazide or chlorthalidone, help the kidneys remove salt and water, and doctors keep an eye on sodium and potassium. Beta blockers, like metoprolol, slow the heart and are used more when there's heart disease too. Many patients need two drugs, so combinations are common, and I'd want to know exactly which gap our product fills."

"I'd welcome it, because a doctor who asks for evidence is taking the product seriously. Every claim on our aid should carry a reference, so I'd show him the study it comes from and sum it up in a few lines: what kind of patients, what it was compared with, for how long, and the main result. I'd be careful to say only what the study showed. If it was done in one group of patients, I wouldn't suggest it applies to everyone. If he wants more, like the statistics or detailed side effect data, I'd offer the full paper through our approved channel or put him in touch with our medical affairs team. I'd rather say 'I'll get that for you' than guess, because one wrong answer about evidence can cost me that doctor's trust."

"There was a cardiologist in my territory who treated reps as a formality; he'd sign for samples and wave me out. I stopped trying to fit a full pitch into every visit. Instead I made sure each call brought one useful thing: a summary of a study relevant to his patients, or an answer to a question he'd asked last time, which I'd get from our medical team. When he mentioned patients struggling with the cost of their tablets, I told him plainly which of our packs could help and which couldn't. After about four months he started asking me questions before I'd said anything, and he asked me to keep his clinic stocked with our patient education leaflets. Trust came from being useful and honest, not from turning up more often."

"I'd thank him and use the time for one message, not five. Say it's a once-daily blood pressure tablet and I know he sees a lot of elderly patients. I'd say something like, 'Doctor, for your older patients who struggle to remember several doses, this is one tablet once a day. Could you try it in your next few newly diagnosed patients and tell me how they get on?' Then I'd leave the reminder card and stop talking. If he asks a question, the thirty seconds becomes three minutes on his terms. If he doesn't, I've still left one clear idea he can remember, which is better than a rushed list he forgets before I reach the door."

"I wouldn't argue or knock the other brand, because he's seen it work. I'd say, 'That makes sense, doctor, it's a good product. Can I ask, are there any patients where you're not fully satisfied, maybe side effects, or people who find it hard to afford long term?' Most doctors can name a few. Then I'd match our brand to that group only, using what our approved material supports, for example a lower-cost pack or a form that's easier to take. And I'd ask for something small: 'Would you try ours in your next five patients like that? I'll check back in two weeks.' I'm not asking him to switch everything. I'm asking for a place in his prescribing, and I earn more of it by coming back with how those patients did."

"Good morning, doctor. You see a lot of patients with diabetes or high blood pressure who also have high LDL cholesterol. Atorvastatin blocks an enzyme in the liver called HMG-CoA reductase, so the liver makes less cholesterol and pulls more LDL out of the blood. That lowers LDL and reduces the risk of heart attack and stroke in patients at raised risk. It's once daily and can be taken at any time of day, which helps patients stick with it. The main things to watch are muscle aches, which patients should report, liver tests as the label advises, and interactions with some other medicines. Doctor, for your next few diabetic patients with high LDL, would you consider starting them on it? I'll come back in two weeks to hear how they're doing."

"Near the end of a quarter at my last company, a large chemist offered to place a big order if I'd record part of it under the previous month, so both his account and my numbers looked better. It would have got me to target. I said no, politely, and explained that orders and invoices have to match what really happened, and that if an audit picked it up it would hurt him as much as me. I offered what I could do legitimately, which was ask the stockist to speed up delivery on his regular orders. I told my manager about it the same day so there'd be no surprises later. I missed target that month by a small amount. My manager backed me, and that chemist still orders from us."

"I'd keep my tone friendly but the answer firm. Something like, 'Doctor, I really can't. Our company rules and the industry codes don't allow anything like that, and linking it to prescriptions would put you at risk as much as me.' Then I'd move to what I can offer: clinical updates, patient education material, or details of approved medical education programmes if the company runs them, all within policy. I'd note it and mention it to my manager, because if the doctor raises it with someone else, the company should know I said no. Most doctors respect a rep who's clear about this. The ones who don't aren't worth risking my job and the company's name over."

"First I'd thank him for telling me and take it seriously, not defend the product. I'd note what he's willing to share: the patient's age and sex or initials, the product and dose, what happened and when, and what was done about it, plus his own contact details. I wouldn't comment on whether our drug caused it, because that's for the safety team to assess, and I wouldn't give any treatment advice. Then I'd report it to our pharmacovigilance team straight away, following our procedure, because the company has strict legal deadlines that start once any employee hears about an event. I'd tell the doctor someone from our safety or medical team may contact him for details. Even if the reaction seems minor or is already listed in the product information, I still report it."

"I'd be straight with him: 'Doctor, that isn't one of its approved uses, so I'm not able to discuss it or make any claims.' But I wouldn't leave him without a route to an answer, because it's a fair clinical question. I'd offer to send his query to our medical information team, who can respond properly with whatever published data exists, and I'd fill in the request form so it's recorded that he asked me, not the other way round. Then I'd bring the conversation back to the approved uses, where I can actually help. Promoting off-label use, even with good intentions, can cost a rep their job and put the company in serious trouble, so I'd rather lose a minute of the call than cross that line."

"It means my report shows exactly what happened that day: the doctors I actually met, not ones I waved at in a corridor, what we discussed, and the samples I gave and to whom. If I only saw six doctors, I report six, even if the standard is higher. Those reports aren't just paperwork. My manager uses them to plan, the company uses the sample records for compliance, and if I pad them, every decision built on them is wrong. It's also about trust. The day a manager finds one fake call, they stop believing anything I report. I'd much rather explain a low number with a real reason than have a high number I can't stand behind."

"This is business the doctor already gave me, so it's urgent. I'd go to the chemist first and ask why he doesn't keep it. Usually it's one of three things: he didn't know prescriptions were coming, the stockist ran out, or he gets a better deal on another brand. I'd show him the doctor is writing it regularly and help him place a small order through our stockist, so his risk is low. I'd check the stockist actually has it, and if not, raise it with my manager and our depot. Then I'd tell the doctor it's in stock next door, and visit that chemist weekly for the next month to see it's moving. I'd also check the other chemists near the clinic so the same gap isn't there."

"The details vary by company and country, but usually the factory sends stock to a company warehouse or depot, the depot supplies stockists or distributors, stockists supply chemists, and the chemist dispenses to the patient against the doctor's prescription. Sales from the company to stockists are usually called primary sales, and sales from stockists on to chemists are secondary sales. My main job is building demand with doctors, but that demand is wasted if the chemist near the clinic doesn't have the product. So I also keep chemists informed, check stock and expiry dates, and stay in touch with the stockist so orders move on time. Secondary sales tell me much more about real demand, because primary sales can be inflated by stock that just sits on shelves."

"The stomach makes acid using a pump in its lining cells, called the proton pump, or the hydrogen potassium ATPase. Pantoprazole blocks that pump, and because it binds to it firmly, acid output stays low for much of the day even though the drug itself leaves the blood fairly quickly. With less acid, reflux symptoms ease and ulcers get the chance to heal. To a doctor I'd add that it works best on active pumps, which is why it's usually taken before the first meal of the day, and that long-term use is worth reviewing from time to time. For a chemist to pass on, I'd keep it to one line: it switches off the stomach's acid pumps, so take it before breakfast, usually half an hour to an hour before, not after the meal."

"Half-life is the time it takes for the amount of drug in the blood to drop by half. It's a big part of why one drug is taken once a day and another three times. A long half-life usually allows less frequent dosing, and it also means the drug takes longer to reach a steady level and longer to wash out. Bioavailability is how much of a dose actually reaches the bloodstream unchanged. A dose given straight into a vein is fully available, while a tablet can lose some in the gut or the liver on the way. A doctor might ask to understand why our dose is once daily, or whether the tablet and injection doses differ. If he wants exact figures, I'd check the product information rather than guess."

"Antibiotic resistance is when bacteria change so that a drug which used to kill them no longer works. Every unnecessary or wrong use gives resistant bacteria a chance to survive and spread. Using antibiotics for viral illnesses like the common cold is a big driver, along with wrong doses and courses changed without the doctor's advice. For me as a rep, that means I promote an antibiotic only for its approved uses, I never suggest it for viral infections or just in case, and I support local treatment guidelines rather than pushing volume. I'd talk about the right patient, the right dose and the right duration. A doctor trusts a rep more when he can see I care about the drug still working years from now."

"Metformin mainly works by reducing how much glucose the liver releases, and it also helps the body's tissues respond better to insulin. It doesn't push the pancreas to release more insulin, so on its own it rarely causes low blood sugar. The side effects a doctor is most likely to raise are stomach problems: nausea, loose stools and discomfort. Starting at a low dose, taking it with meals, and extended-release versions all help. Doctors also check kidney function, because the dose may need lowering, or the drug stopping, if kidney function falls. There's a rare but serious risk called lactic acidosis. And with long-term use vitamin B12 levels can drop, so some doctors check them. I'd answer all of this from the product information and not go beyond it."